RT Journal Article
SR Electronic
T1 Selectively caring for the most severe COVID-19 patients delays ICU bed shortages more than increasing hospital capacity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.05.20222968
DO 10.1101/2020.12.05.20222968
A1 Miles Roberts
A1 Helena Duplechin Seymour
A1 Faculty Advisor
A1 Alexander Dimitrov
YR 2020
UL http://medrxiv.org/content/early/2020/12/07/2020.12.05.20222968.abstract
AB SARS-CoV-2, the virus responsible for COVID-19, has killed hundreds of thousands of Americans. Although physical distancing measures played a key role in slowing COVID-19 spread in early 2020, infection rates are now peaking at record levels across the country. Hospitals in several states are threatened with overwhelming numbers of patients, compounding the death toll of COVID-19. Implementing strategies to minimize COVID-19 hospitalizations will be key to controlling the toll of the disease, but non-physical distancing strategies receive relatively little attention. We present a novel system of differential equations designed to predict the relative effects of hospitalizing fewer COVID-19 patients vs increasing ICU bed availability on delaying ICU bed shortages. This model, which we call SEAHIRD, was calibrated to mortality data on two US states with different peak infection times from mid-March – mid-May 2020. It found that hospitalizing fewer COVID-19 patients generally delays ICU bed shortage more than a comparable increase in ICU bed availability. This trend was consistent across both states and across wide ranges of initial conditions and parameter values. We argue that being able to predict which patients will develop severe COVID-19 symptoms, and thus require hospitalization, should be a key objective of future COVID-19 research, as it will allow limited hospital resources to be allocated to individuals that need them most and prevent hospitals from being overwhelmed by COVID-19 cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was self-funded by the authors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB/oversight was required to conduct this research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll of the data includedin this manuscript is available either in the supplemental section or in the provided links. https://hgis.uw.edu/virus/ https://www.definitivehc.com/resources/covid-19-capacity-predictor https://www.doh.wa.gov/Portals/1/Documents/2300/HospPatientData/YearEnd/Volume2018.xlsx https://kdvr.com/wp-content/uploads/sites/11/2020/03/2018-ICU-Total-and-Licensed-Beds.pdf https://www.census.gov/quickfacts/WA https://www.census.gov/quickfacts/CO